• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

Smiths Medical recalls Medfusion 4000 due to issue with software update

December 19, 2019 By Sean Whooley

Smiths Medical

Smiths Medical has recalled its Medfusion 4000 syringe pump with Firmware version 1.7.0 due to malfunctioning alarms and potential interruption of therapy, FDA said today. The FDA has labeled the recall as Class I, it’s most serious designation. The Medfusion 4000 syringe pump is designed to deliver blood, blood products or prescribed drugs into a patient’s […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance Tagged With: FDA, Smiths Medical

Lilly to integrate DexCom CGMs in automated dosing system

December 16, 2019 By Sean Whooley

Eli Lilly (NYSE:LLY) announced that it will integrate Dexcom (NSDQ:DXCM) products into its personalized diabetes management system, now under development. Under the new, non-exclusive agreement, Indianapolis-based Lilly will use San Diego-based Dexcom’s continuous glucose monitoring (CGM) devices in pen-based and pump-based platforms in Lily’s diabetes management system. The pen-based platform is designed to integrate personalized data from […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: Dexcom, DexCom Inc., Eli Lilly & Co., elililly

3M to sell drug-delivery biz to Altaris Capital Partners for $650m

December 12, 2019 By Sean Whooley

3M (NYSE:MMM) announced today that it entered into an agreement to sell most of its drug-delivery business to an affiliate of Altaris Capital Partners for approximately $650 million. St. Paul, Minn.-based 3M will retain its transdermal drug delivery components business, according to a news release. The business being divested has annual global sales reaching approximately […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Mergers & Acquisitions Tagged With: 3M

J&J’s Ethicon launches Vistaseal fibrin sealant

December 3, 2019 By Sean Whooley

Ethicon

Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon announced today that it launched its Vistaseal fibrin sealant for managing bleeding during surgery. The sealant system is indicated as an adjunct to hemostasis for mild to moderate bleeding in adults undergoing surgery when control of bleeding by standard techniques (suture, ligature, cautery) are ineffective or impractical. Vistaseal fibrin sealant consists […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Hematology, Surgical Tagged With: Ethicon, Grifols

Tissum rases €39m

November 21, 2019 By Sean Whooley

Programmable polymer developer Tissium announced that it raised nearly $43 million in a Series B funding round to support expansion. The company’s funding round reached approximately $42.8 million (€38.8 million) and included new investors BNP Paribas Developpement, the European Investment Fund, M&L Investments and ValQuest Partners, along with returning investors Bpifrance, CM-CIC Innovation, CapDecisif Management, […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Personnel Tagged With: Brigham & Women's Hospital, Mass. Institute of Technology, Tissium

Propeller Health offers access to CVS, other pharmacies with Propeller app

November 19, 2019 By Sean Whooley

Propeller Health updated logo

Propeller Health announced today that users of its Propeller app are now able to access pharmacy services from CVS, Walmart, Kroger and Rite-Aid directly through that app. The Madison, Wis.–based company launched the app in January 2019, giving Walgreens patients the option to manage their asthma or chronic obstructive pulmonary disease medication regimen within the mobile app. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Respiratory Tagged With: Propeller Health

Ocular Therapeutix dips on Q3 losses

November 12, 2019 By Sean Whooley

Ocular Therapeutix logo

Ocular Therapeutix (NSDQ:OCUL) shares fell today on third-quarter results that narrowly topped the consensus forecast despite a bottom-line dip. The Bedford, Mass.–based ophthalmic insert maker posted losses of -$18,778, or -45¢ per share, on sales of $829,000 for the three months ended Sept. 30, for a 25.1% bottom-line slide on sales growth of 66.5%. Adjusted to […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Optical/Ophthalmic Tagged With: Ocular Therapeutix, Ocular Therapeutix Inc

InCarda Therapeutics raises $35 million

November 8, 2019 By Sean Whooley

InCarda Therapeutics

InCarda Therapeutics — which is developing an inhaled paroxysmal atrial fibrillation drug — filed an SEC Form D confirming the sale of more than $35 million in equity. The Newark, Calif.–based drug-device combo company sold nearly $35.3 million since the first sale of the offering occurred on Oct. 20, 2017, according to yesterday’s filing. Get the full […]

Filed Under: Business/Financial News, Cardiovascular, Drug-Device Combinations, Featured, Funding Roundup Tagged With: incardatherapeutics

Insulet Q3 earnings beat The Street despite bottom-line slide

November 6, 2019 By Sean Whooley

Insulet

Insulet (NSDQ:PODD) shares are rising today on third-quarter results that topped the consensus forecast, despite a dip in profits. The Acton, Mass.–based company posted profits of $852,000, or 1¢ per share, on sales of $192.1 million for the three months ended Sept. 30, for a 48.6% bottom-line slide on sales growth of 27.1%. Adjusted to exclude […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Insulet

Log Pharma Packaging launches smart packaging

November 5, 2019 By Sean Whooley

Log Pharma Packaging said today that it is launching its ActiveGuard Connect smart packaging solutions. ActiveGuard Connect is designed to address the lack of patient adherence to prescription medicine or supplementation of nutraceuticals. It is comprised of an integrated desiccant chamber designed to link and synchronize with a patient’s smartphone. The smart packaging product enables […]

Filed Under: Business/Financial News, Featured, mHealth (Mobile Health), Patient Monitoring Tagged With: Log Pharma Packaging

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 68
  • Go to page 69
  • Go to page 70
  • Go to page 71
  • Go to page 72
  • Interim pages omitted …
  • Go to page 76
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS